439 related articles for article (PubMed ID: 35487785)
21. Modification of sphingolipid metabolism by tamoxifen and N-desmethyltamoxifen in acute myelogenous leukemia--Impact on enzyme activity and response to cytotoxics.
Morad SA; Tan SF; Feith DJ; Kester M; Claxton DF; Loughran TP; Barth BM; Fox TE; Cabot MC
Biochim Biophys Acta; 2015 Jul; 1851(7):919-28. PubMed ID: 25769964
[TBL] [Abstract][Full Text] [Related]
22. Emerging Roles of Ceramides in Breast Cancer Biology and Therapy.
Pal P; Atilla-Gokcumen GE; Frasor J
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232480
[TBL] [Abstract][Full Text] [Related]
23. Bioactive sphingolipids in response to chemotherapy: a scope on leukemias.
Ekiz HA; Baran Y
Anticancer Agents Med Chem; 2011 May; 11(4):385-97. PubMed ID: 21453240
[TBL] [Abstract][Full Text] [Related]
24. The clinical potential of sphingolipid-based therapeutics.
Fox TE; Finnegan CM; Blumenthal R; Kester M
Cell Mol Life Sci; 2006 May; 63(9):1017-23. PubMed ID: 16568241
[TBL] [Abstract][Full Text] [Related]
25. Sphingolipids in apoptosis.
Tirodkar TS; Voelkel-Johnson C
Exp Oncol; 2012 Oct; 34(3):231-42. PubMed ID: 23070008
[TBL] [Abstract][Full Text] [Related]
26. Pivotal role of mitophagy in response of acute myelogenous leukemia to a ceramide-tamoxifen-containing drug regimen.
Morad SAF; MacDougall MR; Abdelmageed N; Kao LP; Feith DJ; Tan SF; Kester M; Loughran TP; Wang HG; Cabot MC
Exp Cell Res; 2019 Aug; 381(2):256-264. PubMed ID: 31112736
[TBL] [Abstract][Full Text] [Related]
27. Solving the enigma: Mass spectrometry and small molecule probes to study sphingolipid function.
Millner A; Atilla-Gokcumen GE
Curr Opin Chem Biol; 2021 Dec; 65():49-56. PubMed ID: 34175552
[TBL] [Abstract][Full Text] [Related]
28. Cancer treatment strategies targeting sphingolipid metabolism.
Oskouian B; Saba JD
Adv Exp Med Biol; 2010; 688():185-205. PubMed ID: 20919655
[TBL] [Abstract][Full Text] [Related]
29. Bioactive Sphingolipids in the Pathogenesis of Chronic Obstructive Pulmonary Disease.
Koike K; Berdyshev EV; Bowler RP; Scruggs AK; Cao D; Schweitzer KS; Serban KA; Petrache I
Ann Am Thorac Soc; 2018 Dec; 15(Suppl 4):S249-S252. PubMed ID: 30759004
[TBL] [Abstract][Full Text] [Related]
30. Targeting the Sphingolipid Rheostat in Gliomas.
Zaibaq F; Dowdy T; Larion M
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012521
[TBL] [Abstract][Full Text] [Related]
31. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate.
Kihara A; Mitsutake S; Mizutani Y; Igarashi Y
Prog Lipid Res; 2007 Mar; 46(2):126-44. PubMed ID: 17449104
[TBL] [Abstract][Full Text] [Related]
32. Gene expression of sphingolipid metabolism pathways is altered in hidradenitis suppurativa.
Dany M; Elston D
J Am Acad Dermatol; 2017 Aug; 77(2):268-273.e6. PubMed ID: 28551069
[TBL] [Abstract][Full Text] [Related]
33. Ceramide-induced integrated stress response overcomes Bcl-2 inhibitor resistance in acute myeloid leukemia.
Lewis AC; Pope VS; Tea MN; Li M; Nwosu GO; Nguyen TM; Wallington-Beddoe CT; Moretti PAB; Anderson D; Creek DJ; Costabile M; Ali SR; Thompson-Peach CAL; Dredge BK; Bert AG; Goodall GJ; Ekert PG; Brown AL; D'Andrea R; Robinson N; Pitman MR; Thomas D; Ross DM; Gliddon BL; Powell JA; Pitson SM
Blood; 2022 Jun; 139(26):3737-3751. PubMed ID: 35443029
[TBL] [Abstract][Full Text] [Related]
34. Role of bioactive sphingolipids in physiology and pathology.
Gomez-Larrauri A; Presa N; Dominguez-Herrera A; Ouro A; Trueba M; Gomez-Muñoz A
Essays Biochem; 2020 Sep; 64(3):579-589. PubMed ID: 32579188
[TBL] [Abstract][Full Text] [Related]
35. The sphingolipid salvage pathway in ceramide metabolism and signaling.
Kitatani K; Idkowiak-Baldys J; Hannun YA
Cell Signal; 2008 Jun; 20(6):1010-8. PubMed ID: 18191382
[TBL] [Abstract][Full Text] [Related]
36. Ceramides promote apoptosis for virus-infected lymphoma cells through induction of ceramide synthases and viral lytic gene expression.
Dai L; Trillo-Tinoco J; Bai A; Chen Y; Bielawski J; Del Valle L; Smith CD; Ochoa AC; Qin Z; Parsons C
Oncotarget; 2015 Sep; 6(27):24246-60. PubMed ID: 26327294
[TBL] [Abstract][Full Text] [Related]
37. Druggable Sphingolipid Pathways: Experimental Models and Clinical Opportunities.
Blaho VA
Adv Exp Med Biol; 2020; 1274():101-135. PubMed ID: 32894509
[TBL] [Abstract][Full Text] [Related]
38. Ceramide Metabolism Enzymes-Therapeutic Targets against Cancer.
Gomez-Larrauri A; Das Adhikari U; Aramburu-Nuñez M; Custodia A; Ouro A
Medicina (Kaunas); 2021 Jul; 57(7):. PubMed ID: 34357010
[TBL] [Abstract][Full Text] [Related]
39. Lipids and the cancer stemness regulatory system in acute myeloid leukemia.
Lim INX; Nagree MS; Xie SZ
Essays Biochem; 2022 Sep; 66(4):333-344. PubMed ID: 35996953
[TBL] [Abstract][Full Text] [Related]
40. Sphingolipids in neurodegeneration (with focus on ceramide and S1P).
Wang G; Bieberich E
Adv Biol Regul; 2018 Dec; 70():51-64. PubMed ID: 30287225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
